These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29808511)

  • 1. Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new-generation covered stents.
    Hernández-Enríquez M; Lairez O; Campelo-Parada F; Lhermusier T; Bouisset F; Roncalli J; Elbaz M; Carrié D; Boudou N
    J Interv Cardiol; 2018 Oct; 31(5):617-623. PubMed ID: 29808511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Self-Made Polyurethane-Covered Stent Implantation for the Treatment of Coronary Artery Perforations.
    Song X; Qin Q; Chang S; Xu R; Fu M; Lu H; Ge L; Qian J; Ma J; Ge J
    J Interv Cardiol; 2021; 2021():6661763. PubMed ID: 34104120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a covered stent justifiable in the treatment of coronary artery perforation? An observational analysis of long-term results of two different covered stent types.
    Rosseel L; Scott B; Prihadi E; Azzano A; Degrauwe S; Verheye S; Convens C; Vermeersch P
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):419-425. PubMed ID: 30280487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after new generation single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation.
    Kufner S; Schacher N; Ferenc M; Schlundt C; Hoppmann P; Abdel-Wahab M; Mayer K; Fusaro M; Byrne RA; Kastrati A
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):912-920. PubMed ID: 30467994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry.
    Jurado-Román A; Rodríguez O; Amat I; Romani SA; García-Touchard A; Cruz-González I; Benito-González T; Fernández-Cisnal A; Córdoba-Soriano JG; Subinas A; Hernández-Antolín R; Bayón J; García-Tejada J; Salinas P; Cortés C; Lozano F; Bastante T; Núñez-Gil IJ; Moreno R; López-Sendón JL
    Cardiovasc Revasc Med; 2021 Aug; 29():22-28. PubMed ID: 32859538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term and Long-Term Outcomes After Polytetrafluoroethylene-Covered Stent Implantation for the Treatment of Coronary Perforation.
    Kawamoto H; Tanaka K; Ruparelia N; Takagi K; Yabushita H; Watanabe Y; Mitomo S; Matsumoto T; Naganuma T; Fujino Y; Ishiguro H; Tahara S; Kurita N; Nakamura S; Hozawa K; Nakamura S
    Am J Cardiol; 2015 Dec; 116(12):1822-6. PubMed ID: 26602072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes following Large Vessel Coronary Artery Perforation Treated with Covered Stent Implantation: Comparison between Polytetrafluoroethylene- and Polyurethane-Covered Stents (CRACK-II Registry).
    Bartuś J; Januszek R; Hudziak D; Kołodziejczak M; Kuźma Ł; Tajstra M; Figatowski T; Pawłowski T; Gruz-Kwapisz M; Smolarek-Nicpoń M; Skoczyńska A; Tomasiewicz B; Włodarczak A; Kulczycki J; Plens K; Jaguszewski M; Dobrzycki S; Ochała A; Gąsior M; Reczuch K; Bartuś S; Wojakowski W; Wańha W
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes Following Covered Stent for the Treatment of Coronary Artery Perforation.
    Lee WC; Hsueh SK; Fang CY; Wu CJ; Hang CL; Fang HY
    J Interv Cardiol; 2016 Dec; 29(6):569-575. PubMed ID: 27781308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term outcomes after polytetrafluoroethylene or pericardium covered stenting for grade 3 coronary artery perforations: Insights from G3-CAP registry.
    Pavani M; Cerrato E; Latib A; Ryan N; Calcagno S; Rolfo C; Ugo F; Ielasi A; Escaned J; Tespili M; Conrotto F; Mancone M; Colombo A; Varbella F
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1247-1255. PubMed ID: 30244520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and outcomes of polytetrafluoroethylene covered stents in patients with coronary artery perforation and coronary artery aneurysm: Single center 15-year experience.
    Parikh P; Banerjee K; Sammour Y; Ali AF; Sankaramangalam K; Nair R; Ellis S; Raymond R; Tuzcu EM; Kapadia S
    Catheter Cardiovasc Interv; 2019 Oct; 94(4):555-561. PubMed ID: 31429192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Nagaraja V; Schwarz K; Moss S; Kwok CS; Gunning M
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):1360-1366. PubMed ID: 31850685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
    Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
    Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency polytetrafluoroethylene-covered stent implantation to treat right coronary artery perforation during percutaneous coronary intervention.
    Yorgun H; Canpolat U; Aytemir K; Oto A
    Cardiol J; 2012; 19(6):639-42. PubMed ID: 23224929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.
    Wańha W; Januszek R; Kołodziejczak M; Kuźma Ł; Tajstra M; Figatowski T; Smolarek-Nicpoń M; Gruz-Kwapisz M; Tomasiewicz B; Bartuś J; Łoś A; Jagielak D; Roleder T; Włodarczak A; Kulczycki J; Kowalewski M; Hudziak D; Stachowiak P; Gorący J; Sierakowska K; Reczuch K; Jaguszewski M; Dobrzycki S; Smolka G; Bartuś S; Ochała A; Gąsior M; Wojakowski W
    PLoS One; 2021; 16(5):e0249698. PubMed ID: 33979357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft.
    Lansky AJ; Yang YM; Khan Y; Costa RA; Pietras C; Tsuchiya Y; Cristea E; Collins M; Mehran R; Dangas GD; Moses JW; Leon MB; Stone GW
    Am J Cardiol; 2006 Aug; 98(3):370-4. PubMed ID: 16860026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.